Overview by Region (Quarter)

• Japan: The Company concentrated on enhancing sales activities which match each market; the acute care hospital market, the small and mid-sized hospital market, and the clinic market. The Company also focused on its consumables and services business as well as strengthening its marketing and service capabilities, creating customer value which contributed to improving medical safety, patient outcomes, and operating efficiency. As a result of these initiatives, domestic sales increased. Sales of AEDs increased favorably in the PAD (public access defibrillation) market. Sales in the public hospital and clinic markets increased, while sales in the university market remained flat. Sales in the private hospital market decreased compared to the strong growth due to large orders in the same period of the previous fiscal year.
• International: Overseas sales decreased, due to lower sales in Asia & Other and Latin America, as well as the impact of a change in the fiscal term of Defibtech, LLC according to the reorganization of subsidiaries in the U.S. in the same period of the previous fiscal year. In North America, sales of patient monitors and ventilators achieved double-digit growth, while sales of AEDs decreased. Sales in Latin America decreased mainly in Costa Rica and Columbia compared to the strong performance in the same period of the previous fiscal year, while sales in Mexico increased favorably. Sales in Europe decreased, as sales of AEDs decreased mainly in the U.K. and the Netherlands, while sales in Germany and Turkey increased. In Asia & Other, sales in China decreased. Sales in the Middle East & Africa also decreased compared to the strong growth due to large orders in Morocco in the same period of the previous fiscal year.

 

* In the previous fiscal year, Defibtech, LLC changed its fiscal term from end on December 31 to end on March 31, according to the reorganization of U.S. subsidiaries. In the nine months of FY2023 ended December 31, 2023, Nihon Kohden consolidated the twelve months of Defibtech’s operating results from January 1, 2023 to December 31, 2023.